Pamela Taplay
Overview
Explore the profile of Pamela Taplay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
15
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sedaghat N, Rider N, Rioux W, Teare A, Jones S, Taplay P, et al.
Subst Use Misuse
. 2025 Feb;
60(5):733-741.
PMID: 39980143
Background: Supervised Consumption Sites (SCS) have proven effective in reducing overdose-related deaths by providing safe spaces for people who use substances. However, barriers such as stigma, operating hours, and travel...
2.
Teare A, Rioux W, Rider N, Jones S, Taplay P, Ghosh S
J Subst Use Addict Treat
. 2024 Nov;
168:209567.
PMID: 39510382
Introduction: Overdose response hotlines and apps are novel virtual harm reduction technologies that allow remote monitoring of individuals while they use substances (especially if they use alone) through electronic means....
3.
Seo B, Rioux W, Teare A, Rider N, Jones S, Taplay P, et al.
Harm Reduct J
. 2024 Jul;
21(1):141.
PMID: 39068494
Background: Supervised consumption sites (SCS) and overdose prevention sites (OPS) have been implemented across Canada to mitigate harms associated with illicit substance use. Despite their successes, they still contend with...
4.
Rioux W, Taplay P, Morris-Miller L, Ghosh S
Harm Reduct J
. 2024 May;
21(1):102.
PMID: 38807227
The opioid epidemic remains one of the largest public health crises in North America to date. While there have been many diverse strategies developed to reduce the harms associated with...
5.
Seo B, Rioux W, Rider N, Teare A, Jones S, Taplay P, et al.
J Urban Health
. 2024 Mar;
101(2):252-261.
PMID: 38514599
The COVID-19 pandemic introduced additional health challenges for people who use substances (PWUS) amid the overdose crisis. Numerous harm reduction services, including supervised consumption sites (SCS) across Canada, faced shutdowns...
6.
Seo B, Rider N, Rioux W, Teare A, Jones S, Taplay P, et al.
Harm Reduct J
. 2024 Feb;
21(1):28.
PMID: 38308262
Introduction: Unregulated supply of fentanyl and adulterants continues to drive the overdose crisis. Mobile Overdose Response Services (MORS) are novel technologies that offer virtual supervised consumption to minimize the risk...
7.
Viste D, Rioux W, Cristall N, Orr T, Taplay P, Morris-Miller L, et al.
BMC Public Health
. 2023 Sep;
23(1):1869.
PMID: 37752527
Background: Several novel overdose response technology interventions, also known as mobile overdose response services (MORS), have emerged as adjunct measures to reduce the harms associated with the drug poisoning epidemic....